Javascript must be enabled to continue!
Blood Glucose Fluctuation Is Indicative of Adiposity
View through CrossRef
Introduction: Continuous glucose monitoring (CGM) system is an effective tool for assessing a person’s glycemic control in real-time, in a “free living condition”. Poor glycemic control is strongly linked to cardiovascular disease, obesity, and the pernicious deposition of fat in the abdominal region. Emerging data show that surges in glucose levels after a meal (postprandial glucose excursions) are more tightly linked to cardiovascular disease, insulin resistance, and diabetic complications than the traditional clinical measure of glycemic control using glycated hemoglobin (HbA1c). Therefore, the purpose of this study is to determine if daily glycemic variability as measured by CGM is an indicator of total and regional body fat distribution and how CGM compares with HbA1c measurements. Methods: Twenty-seven volunteers participated in the study (Male: 11, Female: 16, Age: 32.15 ± 14.55 years, BMI: 28.43 ± 7.30 kg/m2). Total body and regional fat distribution (android, gynoid, android/gynoid) were determined using dual-energy x-ray absorptiometry. Fasting blood glucose and glycated hemoglobin (HbA1c) were measured from collected blood samples. Glycemic variability was measured by CGM attached to the abdomen. Results: CGM glycemic variability was positively correlated with total body fat% (r= 0.4278; p= 0.0329), android fat% (r= 0.5313; p= 0.0063), and android/gynoid ratio (r= 0.5981; p= 0.0016). HbA1c was only positively correlated with android/ gynoid ratio (r= 0.5534; p= 0.0041). Conclusion: Higher blood glucose variability/fluctuation measured by CGM was associated with greater body fat, android fat, android/gynoid fat ratio, which are indicators of cardiovascular disease risks. Blood glucose fluctuation monitoring should be considered in blood glucose management. This study was funded by The University of Texas, El Paso Dodson Fund and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) - R01DK132430. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.
American Physiological Society
Title: Blood Glucose Fluctuation Is Indicative of Adiposity
Description:
Introduction: Continuous glucose monitoring (CGM) system is an effective tool for assessing a person’s glycemic control in real-time, in a “free living condition”.
Poor glycemic control is strongly linked to cardiovascular disease, obesity, and the pernicious deposition of fat in the abdominal region.
Emerging data show that surges in glucose levels after a meal (postprandial glucose excursions) are more tightly linked to cardiovascular disease, insulin resistance, and diabetic complications than the traditional clinical measure of glycemic control using glycated hemoglobin (HbA1c).
Therefore, the purpose of this study is to determine if daily glycemic variability as measured by CGM is an indicator of total and regional body fat distribution and how CGM compares with HbA1c measurements.
Methods: Twenty-seven volunteers participated in the study (Male: 11, Female: 16, Age: 32.
15 ± 14.
55 years, BMI: 28.
43 ± 7.
30 kg/m2).
Total body and regional fat distribution (android, gynoid, android/gynoid) were determined using dual-energy x-ray absorptiometry.
Fasting blood glucose and glycated hemoglobin (HbA1c) were measured from collected blood samples.
Glycemic variability was measured by CGM attached to the abdomen.
Results: CGM glycemic variability was positively correlated with total body fat% (r= 0.
4278; p= 0.
0329), android fat% (r= 0.
5313; p= 0.
0063), and android/gynoid ratio (r= 0.
5981; p= 0.
0016).
HbA1c was only positively correlated with android/ gynoid ratio (r= 0.
5534; p= 0.
0041).
Conclusion: Higher blood glucose variability/fluctuation measured by CGM was associated with greater body fat, android fat, android/gynoid fat ratio, which are indicators of cardiovascular disease risks.
Blood glucose fluctuation monitoring should be considered in blood glucose management.
This study was funded by The University of Texas, El Paso Dodson Fund and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) - R01DK132430.
This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format.
There are no additional versions or additional content available for this abstract.
Physiology was not involved in the peer review process.
Related Results
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
Adiposity and metabolic health in Asian populations: An epidemiological study using Dual X-Ray Absorptiometry
Adiposity and metabolic health in Asian populations: An epidemiological study using Dual X-Ray Absorptiometry
AbstractBackgroundDiabetes, cardiovascular disease, and related cardiometabolic disturbances are increasing rapidly in the Asia-Pacific region. We investigated the contribution of ...
Glucose intolerance is associated with resting heart rate among individuals without diabetes
Glucose intolerance is associated with resting heart rate among individuals without diabetes
Elevated resting heart rate is associated with cardiovascular diseases and all-cause mortality. Unmanaged diabetes is associated with high blood pressure and high resting heart rat...
Effects of herbal tea (Platostoma palustre) on blood glucose regulation in vivo
Effects of herbal tea (Platostoma palustre) on blood glucose regulation in vivo
Platostoma palustre jelly is a traditional food. Platostoma palustre has been used as folk medicine and is effective against heat-shock, hypertension and diabetes. Therefore, the a...
Twenty‐four‐hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring
Twenty‐four‐hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring
AbstractAims/IntroductionHigh fluctuations in blood glucose are associated with various complications. The correlation between glycated hemoglobin (HbA1c) level and fluctuations in...
Bioinformatics Analysis of Gefitinib or Rapamycin on Inhibiting the Survival of Hela in the Low Glucose and High Lactic Acid Environment
Bioinformatics Analysis of Gefitinib or Rapamycin on Inhibiting the Survival of Hela in the Low Glucose and High Lactic Acid Environment
Objective: To explore on the antitumor effect of gefitinib and rapamycin and possible mechanism in normal glucose and high lactic acid microenvironment. Methods: Hela cells are cul...
CUT-OFF POINT FOR FASTING GLUCOSE IN DIAGNOSING PREDIABETES
CUT-OFF POINT FOR FASTING GLUCOSE IN DIAGNOSING PREDIABETES
Objective. This study aimed to evaluate the feasibility of using fasting glucose as a primary diagnostic criterion for prediabetes, and to determine the optimal cut-off point for d...
Differences in Blood Glucose Levels of NaF Plasma with Blood Stored at Room Temperature
Differences in Blood Glucose Levels of NaF Plasma with Blood Stored at Room Temperature
Blood glucose is sugar contained in the blood, derived from carbohydrates in the diet, and stored as glycogen in the liver and skeletal muscles. Blood glucose examinations are wide...

